Low Dose Esterified Estrogens: Prevention of Postmenopausal Bone Loss Without Development of Endometrial Hyperplasia

1996 ◽  
Vol 3 (4) ◽  
pp. 223
Author(s):  
M Notelovitz ◽  
R Rebar ◽  
L Speroff ◽  
M Block ◽  
M Greenwald ◽  
...  
Keyword(s):  
Bone Loss ◽  
Endometrial Hyperplasia ◽  
Low Dose ◽  
Postmenopausal Bone Loss

▾ Tibolone (livial) – a new steroid for the menopause

1991 ◽  
Vol 29 (20) ◽  
pp. 77.2-78
Keyword(s):  
Bone Loss ◽  
Endometrial Hyperplasia ◽  
Postmenopausal Bone Loss ◽  
Vaginal Dryness ◽  
Mood Changes ◽  
Intact Uterus ◽  
Loss Of Libido ◽  
Risk Of Cancer

Many women experience troublesome symptoms around the climacteric, particularly vasomotor disturbances such as flushes and sweating, mood changes, insomnia, loss of libido, vaginal dryness and dyspareunia. Oestrogen replacement has become the treatment of choice for these symptoms and is also recommended for the prevention of postmenopausal bone loss in those at particular risk of developing osteoporosis.1,2 Given alone oestrogen may cause endometrial hyperplasia increasing the risk of cancer in women with an intact uterus. Including a progestagen for part of the cycle prevents this, but results in a withdrawal bleed.

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

2009 ◽  
Vol 9 (1) ◽  
pp. 69-73 ◽  
Author(s):  
J.Y. Reginster ◽  
D. Denis ◽  
R. Deroisy ◽  
M.P. Lecart ◽  
M. de Longueville ◽  
...  
Keyword(s):  
Bone Loss ◽  
Salmon Calcitonin ◽  
Low Dose ◽  
Postmenopausal Bone Loss ◽  
Nasal Salmon Calcitonin

Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women

2003 ◽  
Vol 10 (3) ◽  
pp. 241-249 ◽  
Author(s):  
Alessandro Rubinacci ◽  
Elena Peruzzi ◽  
Alberto Bacchi Modena ◽  
Ettore Zanardi ◽  
Bruno Andrei ◽  
...  
Keyword(s):  
Bone Loss ◽  
Low Dose ◽  
Postmenopausal Bone Loss

P307 A two-vear study with low dose, continuous, unopposed esterified estrogens: Prevention of postmenopausal bone loss with minimal endometrial effects

Maturitas ◽  
1996 ◽  
Vol 27 ◽  
pp. 212 ◽  
Author(s):  
J. Lucas ◽  
R. Rebar ◽  
L. Speroff ◽  
J. Trabal ◽  
S. Silfen ◽  
...  
Keyword(s):  
Bone Loss ◽  
Low Dose ◽  
Postmenopausal Bone Loss

Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study

Maturitas ◽  
1997 ◽  
Vol 27 (1) ◽  
pp. 69-76 ◽  
Author(s):  
Hideki Mizunuma ◽  
Hiroya Okano ◽  
Masayuki Soda ◽  
Issei Kagami ◽  
Sumitka Miyamoto ◽  
...  
Keyword(s):  
Bone Loss ◽  
Prospective Study ◽  
Low Dose ◽  
Uterine Bleeding ◽  
Postmenopausal Bone Loss ◽  
Progestin Therapy
Sign in / Sign up

Export Citation Format

Share Document